Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases. Systematic review of all literature and meta-analysis of observational studies

Cancer Treatment Reviews

Volumn 39, Issue 4, 2013, Pages 321-327

  de Cuba, E M V ^a,b   Kwakman, R ^a,b   Knol, D L ^a   Bonjer, H J ^a   Meijer, G A ^a   te Velde, E A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Cancer Center   (Netherlands)

Author keywords

Chemotherapy; Colorectal cancer; Cytoreduction; Hepatectomy; HIPEC; Liver metastases; Peritoneal metastases; RFA

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COHORT ANALYSIS; COLON METASTASIS; COLORECTAL CANCER; CRYOSURGERY; CYTOREDUCTIVE SURGERY; DISSEMINATED CANCER; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; LIVER METASTASIS; LIVER RESECTION; MALIGNANT ASCITES; META ANALYSIS; MULTIMODALITY CANCER THERAPY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONEUM METASTASIS; POSTOPERATIVE CARE; PRACTICE GUIDELINE; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; LIVER NEOPLASMS; OBSERVATION; PERITONEAL NEOPLASMS;

EID: 84875534400     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2012.11.003     Document Type: Review

References (62)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
2. Bird N.C., Mangnall D., Majeed A.W. Biology of colorectal liver metastases: a review. J Surg Oncol 2006, 94(1):68-80.
3. Koppe M.J., Boerman O.C., Oyen W.J.G., Bleichrodt R.P. Peritoneal carcinomatosis of colorectal origin. Ann Surg 2006, 243(2):212-222.
4. Abdalla E.K., Vauthey J.-N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004, 239(6):818-825. [discussion 825-7].
5. Scheele J., Altendorf-Hofmann A. Resection of colorectal liver metastases. Langenbecks Arch Surg 1999, 384(4):313-327.
6. Glehen O. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004, 22(16):3284-3292.
7. Verwaal V.J. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003, 21(20):3737-3743.
8. Jayne D.G., Fook S., Loi C., et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002, 89:1545-1550.
9. de Cuba E.M.V., Kwakman R., van Egmond M., et al. Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: future possibilities for personalised treatment by use of biomarkers. Virchows Arch 2012, 1-31.
10. Elias D., Sideris L., Pocard M., et al. Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 2004, 11(3):274-280.
11. Verwaal V.J., Bruin S., Boot H., van Slooten G., van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008, 15(9):2426-2432.
12. Cao Y., Tan A., Gao F., Liu L., Liao C., Mo Z. A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer. Int J Colorectal Dis 2009, 24(6):677-685.
13. Klaver Y.L.B., Simkens L.H.J., Lemmens V.E.P.P., et al. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol 2012, 38(7):617-623.
14. Franko J., Shi Q., Goldman C.D., et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 2012, 30(3):263-267.
15. Sugarbaker P.H. Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg 1995, 19(2):235-240.
16. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 1995, 221(1):29-42.
17. Verwaal V.J., Kusamura S., Baratti D., Deraco M. The eligibility for local-regional treatment of peritoneal surface malignancy. J Surg Oncol 2008, 98(4):220-223.
18. Elias D., Lefevre J.H., Chevalier J., et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009, 27(5):681-685.
19. Maggiori L., Elias D. Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends. Eur J Surg Oncol 2010, 36(7):599-603.
20. Kianmanesh R., Scaringi S., Sabate J.-M., et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 2007, 245(4):597-603.
21. Elias D., Glehen O., Pocard M., et al. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix. Ann Surg 2010, 251(5):896-901.
22. Aoki T., Umekita N., Tanaka S., Noda K., Warabi M., Kitamura M. Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin. Surgery 2008, 143(6):706-714.
23. Elias D., Ouellet J.F., Bellon N., Pignon J.P., Pocard M., Lasser P. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003, 90(5):567-574.
24. Elias D.M. Peritoneal carcinomatosis or liver metastases from colorectal cancer: similar standards for a curative surgery?. Ann Surg Oncol 2004, 11(2):122-123.
25. Eccles M., Clapp Z., Grimshaw J., et al. North of England evidence based guidelines development project: methods of guideline development. BMJ 1996, 312(7033):760-762.
26. Eccles M., Clapp Z., Grimshaw J., et al. Developing valid guidelines: methodological and procedural issues from the North of England Evidence Based Guideline Development Project. Qual Health Care 1996, 5(1):44-50.
27. Eccles M., Rousseau N., Freemantle N. Updating evidence-based clinical guidelines. J Health Serv Res Policy 2002, 7(2):98-103.
28. Tierney J.F., Stewart L.A., Ghersi D., Burdett S., Sydes M.R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007, 8:16.
29. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
30. Chang A, editor. StatTools [Internet]. Available from: [cited 2012 Jun. 6]. http://www.stattools.net/ForestPlot_Pgm.php.
31. Carmignani C.P., Ortega-Perez G., Sugarbaker P.H. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer. Eur J Surg Oncol 2004, 30(4):391-398.
32. Chua T.C., Yan T.D., Zhao J., Morris D.L. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection. Eur J Surg Oncol 2009, 35(12):1299-1305.
33. Varban O., Levine E.A., Stewart J.H., McCoy T.P., Shen P. Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases. Cancer 2009, 115(15):3427-3436.
34. Cavaliere F., De Simone M., Virzì S., et al. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol 2011, 37(2):148-154.
35. Franko J., Ibrahim Z., Gusani N.J., Holtzman M.P., Bartlett D.L., Zeh H.J. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 2010, 116(16):3756-3762.
36. Mahteme H., Hansson J., Berglund A., et al. Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer 2004, 90(2):403-407.
37. Avital I.Z., Brücher B.L.D.M., Nissan A., Stojadinovic A. Randomized clinical trials for colorectal cancer peritoneal surface malignancy. Surg Oncol Clin N Am 2012, 21(4):665-688.
38. Yan T.D. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006, 24(24):4011-4019.
39. Klaver Y.L.B., Leenders B.J.M., Creemers G.-J., et al. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin. Am J Clin Oncol 2012, [Epub ahead of print].
40. Tol J., Koopman M., Cats A., et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 2009, 360(6):563-572.
41. Koopman M., Antonini N.F., Douma J., et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet 2007, 370(9582):135-142.
42. Sadeghi B., Arvieux C., Glehen O., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000, 88(2):358-363.
43. Chu D.Z., Lang N.P., Thompson C., Osteen P.K., Westbrook K.C. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989, 63(2):364-367.
44. Shen P., Hawksworth J., Lovato J., et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004, 11(2):178-186.
45. Elias D., Benizri E., Pocard M., Ducreux M., Boige V., Lasser P. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 2006, 32(6):632-636.
46. Elias D., Liberale G., Vernerey D., et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 2005, 12(11):900-909.
47. Esquivel J., Elias D., Baratti D., Kusamura S., Deraco M. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 2008, 98(4):263-267.
48. Baratti D, Kusamura S, Deraco M. The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus. J Surg Oncol 2008;98(4):258-62.
49. Carpizo D.R., D'Angelica M. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Lancet Oncol 2009, 10(8):801-809.
50. Yang X.-J., Li Y., Al-shammaa Hassan A.H., et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. Ann Surg Oncol 2008, 16(2):345-351.
51. Pawlik T.M., Schulick R.D., Choti M.A. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008, 13(1):51-64.
52. Carpizo D.R., Are C., Jarnagin W., et al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol 2009, 16(8):2138-2146.
53. Rampone B. Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer. WJG 2010, 16(11):1299.
54. Confuorto G., Giuliano M.E., Grimaldi A., Viviano C. Peritoneal carcinomatosis from colorectal cancer: HIPEC?. Surg Oncol 2007, 16:149-152.
55. Roviello F., Caruso S., Marrelli D., et al. Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol 2011, 20(1):e38-e54.
56. de Haas R.J., Wicherts D.A., Adam R.E. Resection of colorectal liver metastases with extrahepatic disease. Dig Surg 2008, 25(6):461-466.
57. Izzo F., Piccirillo M., Palaia R., Albino V., Di Giacomo R., Mastro A.A. Management of colorectal liver metastases in patients with peritoneal carcinomatosis. J Surg Oncol 2009, 100(4):345-347.
58. Klaver Y.L.B., Lemmens V.E.P.P., Creemers G.J., Rutten H.J.T., Nienhuijs S.W., de Hingh I.H.J.T. Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol 2011, 22(10):2250-2256.
59. Kopetz S., Chang G.J., Overman M.J., et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009, 27(22):3677-3683.
60. Hong Y.S., Kim T.W. Chemotherapy for colorectal cancer. Korean J Gastroenterol 2009, 54(6):355-363.
61. Glockzin G., Renner P., Popp F.C., et al. Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2011, 18(4):1052-1059.
62. Thaler K., Kanneganti S., Khajanchee Y., Wilson C., Swanstrom L., Hansen P.D. The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis. Arch Surg 2005, 140(8):727-734.